e-learning
resources
Vienna 2012
Monday, 03.09.2012
Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Differences in the manegement of latent tuberculosis infection in patients treated with anti-TNF-α in Turkey
S. Ocal, N. Demir, S. Ataman, A. Ugur Demir, N. Suldur, A. Kaya, O. Kayacan (Ankara, Turkey)
Source:
Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Session:
Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Session type:
Thematic Poster Session
Number:
2674
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Ocal, N. Demir, S. Ataman, A. Ugur Demir, N. Suldur, A. Kaya, O. Kayacan (Ankara, Turkey). Differences in the manegement of latent tuberculosis infection in patients treated with anti-TNF-α in Turkey. Eur Respir J 2012; 40: Suppl. 56, 2674
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem…
ERS short guidelines on COVID-19 management
Influenza vaccination: protecting the most vulnerable
Related content which might interest you:
Prevalence of HIV infection among tuberculosis cases and pattern of tuberculosis and treatment outcome in HIV seropositives – a study from a tuberculosis center from India
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009
The dynamics of tuberculosis incidence and diagnostics of latent tuberculosis tuberculosis infection in children of Ukraine.
Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people
Year: 2018
Latent tuberculosis infection among close contacts of multidrugs-resistant tuberculosis patients in eastern Taiwan
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012
Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands
Source: Eur Respir J 2016; 48: 1420-1428
Year: 2016
Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009
Outcomes of treatment of latent tuberculosis infection in children with two different regimens
Source: Eur Respir J 2006; 28: Suppl. 50, 487s
Year: 2006
New skin test with recombinant protein CFP10-ESAT6 in patients (children and adults) with tuberculosis, non-tuberculosis disease and latent TB infection
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1592-1594
Year: 2016
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1594-1595
Year: 2016
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2015; 46: 1397-1406
Year: 2015
Diagnosis and treatment of latent tuberculosis infection
Source: Eur Respir Monogr 2018; 82: 381-398
Year: 2018
Outcome of patients treated for culture-positive pulmonary tuberculosis (CPPTB) in Poland
Source: Eur Respir J 2005; 26: Suppl. 49, 649s
Year: 2005
Recurrent tuberculosis among HIV infected persons in Singapore
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017
Latent tuberculosis infection in children in contact with pulmonary tuberculosis patients
Source: Annual Congress 2010 - Tuberculosis in children
Year: 2010
Risk factors for latent tuberculosis infection in close contacts of active tuberculosis patients in South Korea
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
The cases of active tuberculosis among persons with latent tuberculosis infection residing in the disease hot spots
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016
Management and follow up of non-tuberculosis mycobacteria pulmonary infection in 55 infected cases in Iran
Source: Annual Congress 2011 - Challenges in tuberculosis control
Year: 2011
Diagnosing and treatment of latent tuberculosis infction in children
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009
Different genetics background of patients with latent tuberculosis infection versus active tuberculosis
Source: International Congress 2017 – Asthma genetics and genomics in patients and populations
Year: 2017
Particularities of tuberculosis at children hospitalized with HIV co-infection
Source: Annual Congress 2009 - Tuberculosis at different age groups
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept